Hero Background

hospital acquired bacterial pneumonia ventilator associated bacterial pneumonia

Pathogens, treatment guidelines, off-label therapies, and highly competitive HABP/VABP markets

Hospital-Acquired Bacterial Pneumonia/ Ventilator-Associated Bacterial Pneumonia

Hospital-acquired bacterial pneumonia (HABP) is the most common type of health-care-associated infections (HAIs) and hospital-acquired infections. It is often seen in patients admitted to ICU wards.

About 1 in 10 people admitted to hospitals contract HAIs. The infection causes a financial burden on patients and is a significant cause of morbidity and mortality.

DelveInsight, through its newsletter series, brings to light an overview of the infection, underlying causes, etiology, and symptoms.

The newsletter provides an overview of the prevalence of the disease, the treatment market, and the emerging therapies in the market, transforming the HABP/VABP market landscape.

Download the newsletter by filling up the form and gain access to deep and rich insights into the HABP/VABP market, treatment guidelines, and research taking place in the domain.

Gain access to analytical information related to Life Science vertical directly delivered to your inbox by joining DelveInsight's emailer list and gain a competitive edge.

Stay tuned for more.

Know More About Whats Covered:

  • Indication overview
  • Epidemiological trends
  • Treatment approaches
  • Key Companies
  • Pipeline drugs
  • Collaborations and deals in the domain
  • R&D in the field
  • Top conferences
  • Support from International organizations

More Newsletter Whitepaper